Global Preimplantation Genetic Diagnostics (PGD) Market Size, Status and Forecast 2024-2031

Report ID: 919264 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Preimplantation Genetic Screening
        1.2.3 Preimplantation Genetic Diagnosis
    1.3 Market by Application
        1.3.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Fertility Clinics
        1.3.3 Academic Medical Centers
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2016-2027)
    2.2 Preimplantation Genetic Diagnostics (PGD) Growth Trends by Regions
        2.2.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Share by Regions (2016-2021)
        2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2022-2027)
    2.3 Preimplantation Genetic Diagnostics (PGD) Industry Dynamic
        2.3.1 Preimplantation Genetic Diagnostics (PGD) Market Trends
        2.3.2 Preimplantation Genetic Diagnostics (PGD) Market Drivers
        2.3.3 Preimplantation Genetic Diagnostics (PGD) Market Challenges
        2.3.4 Preimplantation Genetic Diagnostics (PGD) Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue
        3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2016-2021)
        3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2016-2021)
    3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
    3.4 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio
        3.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2020
    3.5 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served
    3.6 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
    3.7 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Type
    4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2016-2021)
    4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2022-2027)

5 Preimplantation Genetic Diagnostics (PGD) Breakdown Data by Application
    5.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Application (2016-2021)
    5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
    6.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type
        6.2.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
        6.2.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
        6.2.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
    6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application
        6.3.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
        6.3.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
        6.3.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
    6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country
        6.4.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
        6.4.2 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
    7.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type
        7.2.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
        7.2.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
        7.2.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
    7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application
        7.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
        7.3.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
        7.3.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
    7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country
        7.4.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
        7.4.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
    8.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type
        8.2.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
    8.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application
        8.3.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
    8.4 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region
        8.4.1 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
    9.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type
        9.2.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
        9.2.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
        9.2.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
    9.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application
        9.3.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
        9.3.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
        9.3.3 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
    9.4 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country
        9.4.1 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
        9.4.2 Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size (2016-2027)
    10.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type
        10.2.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2027)
    10.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application
        10.3.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2027)
    10.4 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country
        10.4.1 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Illumina, Inc.
        11.1.1 Illumina, Inc. Company Details
        11.1.2 Illumina, Inc. Business Overview
        11.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
        11.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.1.5 Illumina, Inc. Recent Development
    11.2 Thermo Fisher Scientific Inc.
        11.2.1 Thermo Fisher Scientific Inc. Company Details
        11.2.2 Thermo Fisher Scientific Inc. Business Overview
        11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
        11.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.2.5 Thermo Fisher Scientific Inc. Recent Development
    11.3 Agilent Technologies, Inc.
        11.3.1 Agilent Technologies, Inc. Company Details
        11.3.2 Agilent Technologies, Inc. Business Overview
        11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
        11.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.3.5 Agilent Technologies, Inc. Recent Development
    11.4 Perkinelmer, Inc.
        11.4.1 Perkinelmer, Inc. Company Details
        11.4.2 Perkinelmer, Inc. Business Overview
        11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
        11.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.4.5 Perkinelmer, Inc. Recent Development
    11.5 Cooper Surgical
        11.5.1 Cooper Surgical Company Details
        11.5.2 Cooper Surgical Business Overview
        11.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction
        11.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.5.5 Cooper Surgical Recent Development
    11.6 ABBott Laboratories
        11.6.1 ABBott Laboratories Company Details
        11.6.2 ABBott Laboratories Business Overview
        11.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction
        11.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.6.5 ABBott Laboratories Recent Development
    11.7 Natera, Inc.
        11.7.1 Natera, Inc. Company Details
        11.7.2 Natera, Inc. Business Overview
        11.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
        11.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.7.5 Natera, Inc. Recent Development
    11.8 Rubicon Genomics
        11.8.1 Rubicon Genomics Company Details
        11.8.2 Rubicon Genomics Business Overview
        11.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
        11.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.8.5 Rubicon Genomics Recent Development
    11.9 Oxford Gene Technology
        11.9.1 Oxford Gene Technology Company Details
        11.9.2 Oxford Gene Technology Business Overview
        11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction
        11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.9.5 Oxford Gene Technology Recent Development
    11.10 Yikon Genomics
        11.10.1 Yikon Genomics Company Details
        11.10.2 Yikon Genomics Business Overview
        11.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
        11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.10.5 Yikon Genomics Recent Development
    11.11 Scigene
        11.11.1 Scigene Company Details
        11.11.2 Scigene Business Overview
        11.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction
        11.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.11.5 Scigene Recent Development
    11.12 Beijing Genomics Institute (BGI)
        11.12.1 Beijing Genomics Institute (BGI) Company Details
        11.12.2 Beijing Genomics Institute (BGI) Business Overview
        11.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction
        11.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.12.5 Beijing Genomics Institute (BGI) Recent Development
    11.13 Genea Limited
        11.13.1 Genea Limited Company Details
        11.13.2 Genea Limited Business Overview
        11.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction
        11.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.13.5 Genea Limited Recent Development
    11.14 Hamilton Thorne
        11.14.1 Hamilton Thorne Company Details
        11.14.2 Hamilton Thorne Business Overview
        11.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction
        11.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.14.5 Hamilton Thorne Recent Development
    11.15 FUJIFILM Irvine Scientific
        11.15.1 FUJIFILM Irvine Scientific Company Details
        11.15.2 FUJIFILM Irvine Scientific Business Overview
        11.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction
        11.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.15.5 FUJIFILM Irvine Scientific Recent Development
    11.16 Nidacon International
        11.16.1 Nidacon International Company Details
        11.16.2 Nidacon International Business Overview
        11.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction
        11.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.16.5 Nidacon International Recent Development
    11.17 Vitrolife AB
        11.17.1 Vitrolife AB Company Details
        11.17.2 Vitrolife AB Business Overview
        11.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction
        11.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.17.5 Vitrolife AB Recent Development
    11.18 Merck
        11.18.1 Merck Company Details
        11.18.2 Merck Business Overview
        11.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction
        11.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.18.5 Merck Recent Development
    11.18 INVO Bioscience
        .1 INVO Bioscience Company Details
        .2 INVO Bioscience Business Overview
        .3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction
        .4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        .5 INVO Bioscience Recent Development
    11.20 IVFtech
        11.20.1 IVFtech Company Details
        11.20.2 IVFtech Business Overview
        11.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction
        11.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.20.5 IVFtech Recent Development
    11.21 Gonagen Medikal
        11.21.1 Gonagen Medikal Company Details
        11.21.2 Gonagen Medikal Business Overview
        11.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction
        11.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.21.5 Gonagen Medikal Recent Development
    11.22 Cook Medical
        11.22.1 Cook Medical Company Details
        11.22.2 Cook Medical Business Overview
        11.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction
        11.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.22.5 Cook Medical Recent Development
    11.23 CellCura
        11.23.1 CellCura Company Details
        11.23.2 CellCura Business Overview
        11.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction
        11.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
        11.23.5 CellCura Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Preimplantation Genetic Screening
    Table 3. Key Players of Preimplantation Genetic Diagnosis
    Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2016-2021)
    Table 8. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2022-2027)
    Table 10. Preimplantation Genetic Diagnostics (PGD) Market Trends
    Table 11. Preimplantation Genetic Diagnostics (PGD) Market Drivers
    Table 12. Preimplantation Genetic Diagnostics (PGD) Market Challenges
    Table 13. Preimplantation Genetic Diagnostics (PGD) Market Restraints
    Table 14. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2016-2021)
    Table 16. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2020)
    Table 17. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
    Table 21. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2016-2021)
    Table 25. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2016-2021)
    Table 29. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Illumina, Inc. Company Details
    Table 62. Illumina, Inc. Business Overview
    Table 63. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product
    Table 64. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 65. Illumina, Inc. Recent Development
    Table 66. Thermo Fisher Scientific Inc. Company Details
    Table 67. Thermo Fisher Scientific Inc. Business Overview
    Table 68. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product
    Table 69. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 70. Thermo Fisher Scientific Inc. Recent Development
    Table 71. Agilent Technologies, Inc. Company Details
    Table 72. Agilent Technologies, Inc. Business Overview
    Table 73. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product
    Table 74. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 75. Agilent Technologies, Inc. Recent Development
    Table 76. Perkinelmer, Inc. Company Details
    Table 77. Perkinelmer, Inc. Business Overview
    Table 78. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product
    Table 79. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 80. Perkinelmer, Inc. Recent Development
    Table 81. Cooper Surgical Company Details
    Table 82. Cooper Surgical Business Overview
    Table 83. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product
    Table 84. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 85. Cooper Surgical Recent Development
    Table 86. ABBott Laboratories Company Details
    Table 87. ABBott Laboratories Business Overview
    Table 88. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product
    Table 89. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 90. ABBott Laboratories Recent Development
    Table 91. Natera, Inc. Company Details
    Table 92. Natera, Inc. Business Overview
    Table 93. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product
    Table 94. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 95. Natera, Inc. Recent Development
    Table 96. Rubicon Genomics Company Details
    Table 97. Rubicon Genomics Business Overview
    Table 98. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 99. Rubicon Genomics Recent Development
    Table 100. Oxford Gene Technology Company Details
    Table 101. Oxford Gene Technology Business Overview
    Table 102. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product
    Table 103. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 104. Oxford Gene Technology Recent Development
    Table 105. Yikon Genomics Company Details
    Table 106. Yikon Genomics Business Overview
    Table 107. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product
    Table 108. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 109. Yikon Genomics Recent Development
    Table 110. Scigene Company Details
    Table 111. Scigene Business Overview
    Table 112. Scigene Preimplantation Genetic Diagnostics (PGD) Product
    Table 113. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 114. Scigene Recent Development
    Table 115. Beijing Genomics Institute (BGI) Company Details
    Table 116. Beijing Genomics Institute (BGI) Business Overview
    Table 117. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product
    Table 118. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 119. Beijing Genomics Institute (BGI) Recent Development
    Table 120. Genea Limited Company Details
    Table 121. Genea Limited Business Overview
    Table 122. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product
    Table 123. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 124. Genea Limited Recent Development
    Table 125. Hamilton Thorne Company Details
    Table 126. Hamilton Thorne Business Overview
    Table 127. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product
    Table 128. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 129. Hamilton Thorne Recent Development
    Table 130. FUJIFILM Irvine Scientific Company Details
    Table 131. FUJIFILM Irvine Scientific Business Overview
    Table 132. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product
    Table 133. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 134. FUJIFILM Irvine Scientific Recent Development
    Table 135. Nidacon International Company Details
    Table 136. Nidacon International Business Overview
    Table 137. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product
    Table 138. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 139. Nidacon International Recent Development
    Table 140. Vitrolife AB Company Details
    Table 141. Vitrolife AB Business Overview
    Table 142. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product
    Table 143. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 144. Vitrolife AB Recent Development
    Table 145. Merck Company Details
    Table 146. Merck Business Overview
    Table 147. Merck Preimplantation Genetic Diagnostics (PGD) Product
    Table 148. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 149. Merck Recent Development
    Table 150. INVO Bioscience Company Details
    Table 151. INVO Bioscience Business Overview
    Table 152. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product
    Table 153. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 154. INVO Bioscience Recent Development
    Table 155. IVFtech Company Details
    Table 156. IVFtech Business Overview
    Table 157. IVFtech Preimplantation Genetic Diagnostics (PGD) Product
    Table 158. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 159. IVFtech Recent Development
    Table 160. Gonagen Medikal Company Details
    Table 161. Gonagen Medikal Business Overview
    Table 162. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product
    Table 163. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 164. Gonagen Medikal Recent Development
    Table 165. Cook Medical Company Details
    Table 166. Cook Medical Business Overview
    Table 167. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product
    Table 168. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 169. Cook Medical Recent Development
    Table 170. CellCura Company Details
    Table 171. CellCura Business Overview
    Table 172. CellCura Preimplantation Genetic Diagnostics (PGD) Product
    Table 173. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021) & (US$ Million)
    Table 174. CellCura Recent Development
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2020 VS 2027
    Figure 2. Preimplantation Genetic Screening Features
    Figure 3. Preimplantation Genetic Diagnosis Features
    Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2027
    Figure 5. Fertility Clinics Case Studies
    Figure 6. Academic Medical Centers Case Studies
    Figure 7. Others Case Studies
    Figure 8. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
    Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Preimplantation Genetic Diagnostics (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions: 2020 VS 2027
    Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2022-2027)
    Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2020
    Figure 14. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2020
    Figure 16. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2016-2021)
    Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2022-2027)
    Figure 18. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
    Figure 20. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
    Figure 21. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
    Figure 22. United States Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
    Figure 26. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
    Figure 27. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
    Figure 28. Germany Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Preimplantation Genetic Diagnostics (PGD) Market Share by Region (2016-2027)
    Figure 38. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
    Figure 46. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
    Figure 47. Latin America Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
    Figure 48. Mexico Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Preimplantation Genetic Diagnostics (PGD) Market Share by Country (2016-2027)
    Figure 54. Turkey Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 59. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 60. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 61. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 62. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 63. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 64. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 65. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 66. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 67. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 68. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 69. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 70. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 71. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 72. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 73. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 74. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 75. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 76. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 77. Gonagen Medikal Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 78. Cook Medical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 79. CellCura Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Frequently Asked Questions
Preimplantation Genetic Diagnostics (PGD) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Preimplantation Genetic Diagnostics (PGD) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Preimplantation Genetic Diagnostics (PGD) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports